Trainor is apparently leveraging every avenue she can get to "biohack" her body and turn back the clock, according to an ET interview on Instagram
[DOI] [PubMed] [Google Scholar] 133.Cohen MA, Ellis SM, Le Roux CW, et al
doi: 10.1038/s41417-021-00352-2 112 KumarBSinghABasarRUpretyNLiYFanHet al
However, Epithalon's promise comes with important caveats - most research conducted in Russia with limited Western validation, no FDA approval or large-scale international trials, long-term human safety data spanning years not decades, optimal dosing still based on Russian protocols rather than rigorous dose-finding studies, and mechanisms incompletely understood despite 40 years of research
These predispositions should be interpreted with a qualified healthcare provider to inform whether a GLP-1-centered strategy aligns with your metabolic biology
This long half-life means timing variation within a 24-48 hour window does not materially affect drug exposure or efficacy in clinical studies
